ACR Appropriateness Criteria® Chronic Liver Disease
, Mustafa R Bashir1, Jeanne M Horowitz2
1Duke University Medical Center, Durham, North Carolina.
Summary
Accurate liver fibrosis staging is crucial for managing chronic liver diseases. Advanced imaging techniques like elastography offer better assessment of early fibrosis and hepatocellular carcinoma surveillance, guiding clinical decisions.
Area of Science:
- Hepatology and Medical Imaging
- Clinical Diagnostics and Therapeutics
Background:
- Liver fibrosis staging is critical for morbidity and mortality in chronic liver diseases.
- Accurate diagnosis and staging are vital as fibrosis can be stabilized or reversed with new therapies.
Framework:
- Conventional imaging (Ultrasound, CT, MRI) aids advanced fibrosis/cirrhosis diagnosis but not early stages.
- Elastography-based ultrasound and MRI are superior for precirrhotic hepatic fibrosis assessment.
- American College of Radiology Appropriateness Criteria guide imaging selection.
Implementation:
- Ultrasound is the primary surveillance for hepatocellular carcinoma (HCC) in advanced fibrosis.
- Multiphase CT or MRI are alternatives for HCC surveillance when ultrasound is suboptimal (e.g., obesity, severe steatosis).
- CT and MRI support continued HCC surveillance post-treatment; contrast-enhanced ultrasound is emerging.
Implications:
- Improved diagnostic accuracy for liver fibrosis stages impacts patient outcomes.
- Enhanced surveillance strategies for HCC can lead to earlier detection and intervention.
- Evidence-based guidelines facilitate appropriate use of imaging modalities in liver disease management.
Keywords:
AUCAppropriate Use CriteriaAppropriateness CriteriaCirrhosisElastographyFibrosisHepatocellular carcinomaImagingLiver diseaseMore Related Videos
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
120
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
156
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
156
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
132
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
132
01:29Chronic Pancreatitis II: Collaborative Care
224
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
224
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
418
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
418
01:26Diseases of the Liver and Gallbladder
1.7K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.7K